Carl Zeiss Meditec shows solid recovery signs, especially in China/US, with strong growth in equipment and consumables. Read ...

J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec (0DHC – Research Report) today. The company’s shares closed ...

Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it saw a significant share price rise ...

O n Wednesday, Goldman Sachs analyst Richard Felton upgraded Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY), a medical technology company with a $5.2 billion market cap, from Sell to Neutral and ...

Hauck & Aufhaeuser analyst Alexander Galitsa maintained a Buy rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price ...

Carl Zeiss Meditec reported a fall in net profit for the first quarter of fiscal 2025 despite a slight uptick in revenue, as it warned of a continuing challenging macroeconomic environment.

Despite these challenges, Carl Zeiss Meditec's EBITA reached €35.2 million, only €2.5 million below the Vara consensus of €38.1 million. This decline in EBITA was partly due to a decrease in ...

(Il Sole 24 Ore Radiocor) - Milano, 11 mar - Carl Zeiss Meditec shares were sharply higher in Frankfurt trade after Goldman Sachs raised its recommendation on the German medical technology group ...

(RTTNews) - Carl Zeiss Meditec AG (CZMWY), a medical technology company, Wednesday announced a decrease in its first-quarter profit. For the first quarter, net profit dropped to 15.7 million euros ...

Carl Zeiss Meditec AG (“Carl Zeiss”) is proud to honor EuroEyes International Eye Clinic Limited (“EuroEyes International” or the “Company”) for achieving the prestigious title of the most AT LISA® ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...